Patents by Inventor Igor Spigelman

Igor Spigelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN
    Publication number: 20170240521
    Abstract: Peripherally acting cannabinoid agonist compounds, pharmaceutical compositions, and methods of using them are presented.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 24, 2017
    Applicant: The Regents of the University of California
    Inventors: Igor Spigelman, Herbert H. Seltzman, Craig Shiner
  • Peripherally-acting cannabinoid receptor agonists for chronic pain
    Patent number: 9656981
    Abstract: Peripherally acting cannabinoid agonist compounds, pharmaceutical compositions, and methods of using them are presented.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: May 23, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Igor Spigelman, Herbert H. Seltzman, Craig Shiner
  • PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN
    Publication number: 20150239859
    Abstract: Peripherally acting cannabinoid agonist compounds, pharmaceutical compositions, and methods of using them are presented.
    Type: Application
    Filed: July 19, 2013
    Publication date: August 27, 2015
    Inventors: Igor Spigelman, Herbert H. Seltzman, Craig Shiner
  • Methods of Treating Alcohol Intoxication, Alcohol Use Disorders and Alcohol Abuse Which Comprises the Administration of Dihydromyricetin
    Publication number: 20130053435
    Abstract: Disclosed herein are methods for treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin. As disclosed herein, dihydromyricetin potentiates the activity of GABAARs having the alpha4-beta-delta subunit which is associated with the effects of ethanol, antagonizes the actions of ethanol on the GABAARs, acts on the benzodiazepine sites of GABAARs, and inhibits, reduces and/or reverses some or all of the GABAAR plasticity which is caused by exposure to ethanol.
    Type: Application
    Filed: August 23, 2011
    Publication date: February 28, 2013
    Inventors: Jing Liang, Richard W. Olsen, Igor Spigelman